---
$id: https://graph.org.ai/products/commodity/51151539
$type: Product
source: UNSPSC
code: "51151539"
title: "Cevimeline hydrochloride hemihydrate"
class: "51151500"
classTitle: "Cholinergic drugs and cholinesterase inhibitors"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cevimeline hydrochloride hemihydrate

**UNSPSC Code**: 51151539
**Class**: [Cholinergic drugs and cholinesterase inhibitors](Cholinergic drugs and cholinesterase inhibitors.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a cholinergic agonist with the molecular formula 2C10H17NOS.2ClH.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P81Q6V85NP, chemically known as (+/-)-cis-2-methylspiro(1,3-oxathiolane-5,3'-quinuclidine)hydrochloride, hemihydrate, but more generally known as cevimeline hydrochloride hemihydrate, which bears US NIH Compound Identifier 83927. European Medicines Agency schedules cevimeline hydrochloride hemihydrate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07461MIG. Most nations, for tariff purposes, schedule cevimeline hydrochloride hemihydrate under HS 29349990. SMILES: C[C@H]1O[C@@]2(CN3CCC2CC3)CS1.C[C@H]1O[C@@]2(CN3CCC2CC3)CS1.O.CL.CL.

